NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission this week, PerkinElmer disclosed that it paid $63.5 million in cash to acquire Bioo Scientific, a deal the firm originally disclosed during its second quarter earnings conference call in August. In its SEC filing, PerkinElmer also said it had acquired a second, unnamed company in 2016 for $8.8 million.